Long-term outcomes of tepotinib in patients with MET exon 14 skipping NSCLC from the VISION study Meeting Abstract
| Authors: | Paik, P. K.; Garassino, M. C.; Le, X.; Thomas, M.; Sakai, H.; Veillon, R.; Smit, E. F.; Mazieres, J.; Cortot, A. B.; Raskin, J.; Viteri, S.; Yang, J. C. H.; Ahn, M. J.; Wu, Y. L.; Zhao, J.; Adrian, S.; Berghoff, K.; Bruns, R.; Johne, A.; Felip, E. |
| Abstract Title: | Long-term outcomes of tepotinib in patients with MET exon 14 skipping NSCLC from the VISION study |
| Meeting Title: | 2023 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 41 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2023 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2023-06-01 |
| Language: | English |
| DOI: | 10.1200/JCO.2023.41.16_suppl.9060 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting abstract: 9060 -- Meeting also presented virtually -- Source: Cinahl |
